title: Heart rate variability and Parkinson's disease severity.
abstract: Heart rate variability (HRV) decrease in Parkinson's disease (PD) could only be a consequence of reduce motor activity besides of being a marker of cardiovascular dysautonomia. Under continuously recorded and standardised motor activity, we studied thirty patients compared to controls in 3 PD stages: group I: less than 2 year-evolution, slight impaired without L-dopa; group II: mildly impaired with L-dopa; group III: advanced PD with motor complications. No difference was observed between group I and controls. The diurnal low frequency power (LF) and the ratio of LF/high frequency (HF) power decreased in groups II and III. The nocturnal vagal indicators: HF power and pNN50 were decreased in group III. Those parameters were correlated with Off-drug-motor handicap, suggesting an evolutive HRV decrease with disease severity but not with On-drug-motor activity. The low LF despite the higher motor activity in group III, due to dyskinesias, suggested a defective cardiovascular up-regulation.
authors.affiliation: Department of Neurology, EA 2683, CHU Lille, France. d-devos@chru-lille.fr
authors.forename: D
authors.initials: D
authors.lastname: Devos
authors.forename: M
authors.initials: M
authors.lastname: Kroumova
authors.forename: R
authors.initials: R
authors.lastname: Bordet
authors.forename: H
authors.initials: H
authors.lastname: Vodougnon
authors.forename: J D
authors.initials: JD
authors.lastname: Guieu
authors.forename: C
authors.initials: C
authors.lastname: Libersa
authors.forename: A
authors.initials: A
authors.lastname: Destee
mesh_terms: D001342:Autonomic Nervous System Diseases / Q000175:diagnosis / Q000209:etiology* / Q000503:physiopathology*; D002319:Cardiovascular System / Q000503:physiopathology; D021081:Chronobiology Disorders / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology; D018450:Disease Progression; D005260:Female; D006339:Heart Rate / Q000187:drug effects / Q000502:physiology; D006801:Humans; D018476:Hypokinesia / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D007980:Levodopa / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology*; D011795:Surveys and Questionnaires; D013564:Sympathetic Nervous System / Q000503:physiopathology; D015854:Up-Regulation / Q000187:drug effects / Q000502:physiology; D014630:Vagus Nerve / Q000503:physiopathology
chemical_list: D007980:Levodopa